Drug of Abuse Testing Services Market Share, Size, Trends, Industry Analysis Report, By Product (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others); By End-Use (Government, Private, Specialty Centers); By Regions; Segment Forecast, 2021 - 2028
- Published Date:Apr-2021
- Pages: 122
- Format: PDF
- Report ID: PM1867
- Base Year: 2020
- Historical Data: 2016-2019
Report Outlook
The global drug of abuse testing services market was valued at USD 2.70 billion in 2020 and is expected to grow at a CAGR of 5.4% during the forecast period. Over the past few years, there has been an increase in the consumption of illicit drugs, alcohol, and other recreational chemicals particularly among the younger generation in the developed countries.
Product innovations, technological advancements, and the introduction of regulatory policies have been detailed in the report to enable businesses to make more informed decisions. Furthermore, the impact of the COVID-19 pandemic on the drug of abuse testing services market demand has been examined in the study. The report is a must-read for anyone looking to develop effective strategies and stay ahead of the curve.
Know more about this report: request for sample pages
There is a rise in government monitoring to contain drug abuse also significantly driving the testing services market growth. According to the statistics published by the U.S.-based dedicated organization, United Nations Office on Drugs and Crime (UNODC), in 2019, approximately 35 million people across the globe are suffering from drug abuse disorders and are seeking testing and treatment services.
It is also being estimated that there are over 188 million users of cannabis all over the world. Moreover, National Center for Drug Abuse Statistics (NCDAS), estimated that there are around 1.5 to 5 percent of the diseases diagnosed through testing are due to illegal consumption of drugs and other recreational chemicals.
Moreover, based on the Federal Drug-Free Workplace program norms, a condition under which all federal employees must avoid consumption of any kind during office hours. It facilitates the certification of agencies free from the illicit use of drugs and initiates potential sources for potential toxicology testing services centers. SAMHSA center of drug abuse testing services also supervises certified labs to work under the mandated guidelines.
Adoption of such programs to test drug abuse in few sensitive institutions like law enforcement, public health and safety, and national security is expected to drive the testing services market. All testing services provided by both public and private entities should be in accordance with legal considerations. Such authorities have all power and legal mandate to decide the condition and situation under which testing services should be provided.
Know more about this report: request for sample pages
Drug of Abuse Testing Services Market Report Scope
The market is primarily segmented on the basis of drug type, end-use, and region.
|
By Drug Type |
By End-Use |
By Region |
|
|
|
Know more about this report: request for sample pages
Insight by Drug Type
The cannabis abuse testing services market segment accounted for the largest revenue share in 2020. This high share is attributed to its highest consumption all over the world. As per the market statistics published by the Substance Abuse and Mental Health Services Administration, in 2018, a particular drug was commonly used in the U.S., and it is being estimated that over 43.5 million people are regular users.
However, the opioids abuse testing services market segment witness to register highest growth over the market study period. Such growth is due to the ongoing opioid crisis in western countries. According to the data stated by the National Center for Drug Abuse Statistics, in 2018, more than 2 million individuals in the U.S. are a victim of the opioid crisis.
The most prominent among these include heroin and prescription-based pain relievers. Moreover, key players in the market for drug of abuse testing services are introducing organic strategies to expand their capabilities for opioid abuse testing market.
Geographic Overview
In 2020, North America drug of abuse testing services market accounted for the largest revenue share and is expected to maintain its dominance over the assessment period. Key factors responsible for the testing services market growth include the rising prevalence of substance abuse and the opioid crisis in the region.
Moreover, stronger government measures and the ongoing situation of COVID-19 in the region also favored the increase in consumption of illicit drugs. However, country-wise lockdowns reduced the market demand for workplace drug testing services, owing to the dormant market growth scenario.
However, Asia Pacific drug of abuse testing services is projected to witness the highest market growth over the assessment period. The increasing prevalence of drug abuse among Asian countries coupled with improving testing capabilities is primarily responsible for such market growth. However, lack of transparent policies towards workplace testing, and country-wise lockdowns may hamper the region’s drug of abuse testing services market growth.
Competitive Insight
The prominent players operating in the market are Quest Diagnostics, United States Drug Testing Laboratories (USDTL), Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Clinical Reference Laboratory (CRL), Inc., Cordant Health Solutions, DrugScan, Omega Laboratories, Inc., Legacy Medical Services, Psychemedics Corporation, Mayo Clinic Laboratories, Precision Diagnostics, Millennium Health, American Substance Abuse Professionals (ASAP), Inc., and LGC Group.
We strive to offer our clients the finest in market research with the most reliable and accurate research findings. We use industry-standard methodologies to offer a comprehensive and authentic analysis of the drug of abuse testing services market. Besides, we have stringent data-quality checks in place to enable data-driven decision-making for you.
